IKT SEC Filings | SEC Document SEARCH
Back to Search
Inhibikase Therapeutics, Inc. (IKT)
Ticker: IKT
CIK: 0001750149
36
Filings Found (Last 1 Year)
Filter Filings
All
8-K
2026. 9. 8.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
8-K
2026. 8. 21.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
10-Q
2026. 6. 30.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Quarterly report
10-Q
Open Filing
8-K
2026. 8. 11.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
4
2026. 7. 29.
RA Capital Healthcare Fund LP (CIK 0001315082)
Insider trading report
Open Filing
4
2026. 7. 30.
BERMAN DENNIS N (CIK 0001273858)
Insider trading report
4
Open Filing
8-K
2026. 7. 29.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
8-K
2026. 7. 23.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
8-K
2026. 7. 14.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
4
2026. 6. 26.
BERMAN DENNIS N (CIK 0001273858)
Insider trading report
4
Open Filing
4
2026. 6. 26.
Canner David (CIK 0002041173)
Insider trading report
4
Open Filing
4
2026. 6. 26.
Kush Arvind (CIK 0001986806)
Insider trading report
4
Open Filing
4
2026. 6. 26.
Bellini Roberto (CIK 0001802453)
Insider trading report
4
Open Filing
4
2026. 6. 26.
Aurentz Vincent (CIK 0001657494)
Insider trading report
4
Open Filing
4
2026. 6. 26.
Munshi Amit (CIK 0001612551)
Insider trading report
4
Open Filing
8-K
2026. 6. 26.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
10-Q
2026. 3. 31.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Quarterly report
10-Q
Open Filing
8-K
2026. 5. 12.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
8-K
2026. 4. 7.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
10-K
2025. 12. 31.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Annual report
10-K
Open Filing
8-K
2026. 3. 26.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
4
2026. 2. 21.
Aurentz Vincent (CIK 0001657494)
Insider trading report
4
Open Filing
4
2026. 2. 21.
Cabell Christopher (CIK 0001814928)
Insider trading report
4
Open Filing
4
2026. 2. 21.
Munshi Amit (CIK 0001612551)
Insider trading report
4
Open Filing
4
2026. 1. 5.
Iwicki Mark T (CIK 0001415537)
Insider trading report
4
Open Filing
4
2026. 1. 5.
Cabell Christopher (CIK 0001814928)
Insider trading report
4
Open Filing
4
2026. 1. 5.
McIntyre David (CIK 0001404254)
Insider trading report
4
Open Filing
8-K
2025. 12. 19.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
424B5
2025. 12. 19.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Prospectus
424B5
Open Filing
4
2025. 11. 21.
Sands Capital Alternatives, LLC (CIK 0001846444)
Insider trading report
PRIMARY DOCUMENT
Open Filing
8-K
2025. 11. 20.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
424B5
2025. 11. 21.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Prospectus
424B5
Open Filing
424B5
2025. 11. 20.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Prospectus
424B5
Open Filing
8-K
2025. 11. 20.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
10-Q
2025. 9. 30.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Quarterly report
10-Q
Open Filing
8-K
2025. 11. 14.
Inhibikase Therapeutics, Inc. (IKT) (CIK 0001750149)
Current report
8-K
Open Filing
Previous
Page 1 of 2
Next
